Latest News & Features
Americas
Balancing a company’s duty to shareholders with the public responsibility to provide lifesaving treatments is a constant challenge, as Issi Rozen, chief business officer at the Broad Institute of MIT and Harvard, tells LSIPR. 4 July 2018
Americas
With his interests in IP development, biotechnology innovation policy, and R&D, Luiz Otávio Pimentel, president of Brazil’s patent office, tells LSIPR of his aims to improve the country’s IP performance. 3 July 2018
Europe
Brexit has created many uncertainties in the IP arena and the CEO of the UK Intellectual Property Office is urging stakeholders to speak up, so that the office isn’t the “lone voice” advocating the importance of IP. 2 July 2018
Asia
Speaking to LSIPR Leena Menghaney, regional head of Médecins Sans Frontières’ Access Campaign in South Asia, explains the importance of a balanced IP policy in fostering healthy generic competition. 2 July 2018
Big Pharma
In order to maximise the value from the patent search process, IP practitioners should take note of several tips including offering clear guidance to the searcher—and even saying ‘thank you’. Ellen Sherin of GQ Life Sciences reports. 14 June 2018
Americas
The healthcare industry and governments around the world are turning to precision medicine as an opportunity and a potential saviour. Daniel Lim of Kirkland & Ellis discusses the issues around translating the promise of precision medicine into real world clinical practice. 13 June 2018
Europe
C5’s International Pharma Patent Term Extensions Forum, which will be held in Munich, Germany on June 19 and 20, will provide guidance on patent term extensions in the world’s key IP regions, as LSIPR finds out. 4 June 2018
Americas
Drug companies can take heart from a range of best practices in the battle against counterfeit medicines, as LSIPR finds out. 4 June 2018
Big Pharma
With Brexit looming, questions are being asked about the future regulatory relationship between the EU and the UK, with life sciences companies wondering how they will be affected. LSIPR reports. 4 June 2018
Americas
As innovation in the CRISPR field continues across the world, questions are being asked about the role of regulating such a powerful tool, while discussions around licensing the technology continue, as LSIPR reports. 4 June 2018